Asprosin: A Novel Player in Metabolic Diseases

Overview of attention for article published in Frontiers in endocrinology, February 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 2 X users
patent: 1 patent

wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 71 Dimensions

Readers on

mendeley: 139 Mendeley

Summary X Patents Wikipedia Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,878 followers.

Asprosin: A Novel Player in Metabolic Diseases. https://t.co/DCV54MaIBA

11 Mar 2020

Reply Repost Favourite

New Research: Asprosin: A Novel Player in Metabolic Diseases: Asprosin, a novel glucogenic adipokine, is encoded by two exons (exon 65 and exon 66) of the gene Fibrillin 1 (FBN1) and mainly synthesized and released by white adipose… https://t.co/uRwx53W0E5

20 Feb 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.